| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Joan Stafslien last filed a Form 4 in June 2021, as Director at VTAK. Joan Stafslien's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 8,410 shares of VTAK. Net of sales, the VTAK filings show accumulation of 4,410 shares.
Joan Stafslien has 4 Form 4 filings on record from April 2020 to June 2021, all as Director at Catheter Precision (VTAK), 2020–2021.
The 4 reported transactions were 3 stock awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $25K and no sales.
The only open-market purchase was 4,410 shares of VTAK at an average $5.67 on November 19, 2020, about $25K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2020 | VTAK Catheter Precision, Inc. | Director | Buy | 4,410 | $5.67 | $25,002.50 | New |